X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-23 | ABT | Abbott Laboratories | Ford Robert B | COB, CEO | P - Purchase | $107.13 | +18,800 | 469,508 | +4% | +$2,013,967 | ||||||
2026-01-23 | ALLY | Ally Financial Inc. | Rhodes Michael George | CEO | P - Purchase | $41.68 | +23,800 | 340,381 | +8% | +$991,867 | ||||||
2026-01-27 | ALLY | Ally Financial Inc. | Hutchinson Russell E. | CFO | P - Purchase | $43.17 | +11,566 | 231,336 | +5% | +$499,307 | ||||||
2026-01-22 | CVM | Cel Sci Corp | Kersten Geert R | CEO | P - Purchase | $5.26 | +38,023 | 120,815 | +46% | +$200,001 | ||||||
| D | 2026-01-26 | EQPT | Equipmentshare.Com Inc | Marquardt David | CFO, Chief Accounting Officer | P - Purchase | $24.50 | +4,285 | 64,285 | +7% | +$104,983 | |||||
| AD | 2026-01-26 | HLXC | Helix Acquisition Corp. III | Chen Bihua | Chairperson, CEO, 10% | P - Purchase | $10.00 | +800,000 | 800,000 | New | +$8,000,000 | |||||
2026-01-26 | INTC | Intel Corp | Zinsner David | EVP, CFO | P - Purchase | $42.50 | +5,882 | 247,392 | +2% | +$249,985 | ||||||
2026-01-26 | LOB | Live Oak Bancshares, Inc. | Stasiowska Ewa Maria | Chief Risk Officer | P - Purchase | $38.53 | +2,595 | 2,595 | New | +$99,999 | ||||||
| D | 2026-01-22 | QTIH | Qt Imaging Holdings, Inc. | Katz Avi S | COB | P - Purchase | $6.43 | +24,107 | 413,452 | +6% | +$155,008 | |||||
2026-01-23 | RLI | Rli Corp | Kliethermes Craig W | CEO | P - Purchase | $57.45 | +5,000 | 143,990 | +4% | +$287,250 | ||||||
2026-01-23 | RLI | Rli Corp | Klobnak Jennifer L | COO | P - Purchase | $57.99 | +2,000 | 100,318 | +2% | +$115,980 | ||||||
2026-01-27 | SCISX | Ma Specialty Credit Income Fund | Marra Joseph P. | Pres, Prin. Ex. Officer | P - Purchase | $24.95 | +2,004 | 12,610 | +19% | +$50,000 | ||||||
2026-01-23 | STEX | Streamex Corp. | Williams Mitchell Young | Chief Investment Officer | P - Purchase | $3.03 | +51,511 | 1,051,511 | +5% | +$155,852 | ||||||
2026-01-26 | ZIVO | Zivo Bioscience, Inc. | Payne John Bernard | Pres, CEO | P - Purchase | $8.54 | +11,709 | 19,618 | +148% | +$99,995 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |